Financial Statements · Financial Reporting
Asper Biogene OÜ
Official identifier 14265334Record date 31 Dec 2021
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2021
- Period start
- 1 Jan 2021
- Submitted date
- 30 Jun 2022
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 422,487 |
| Balance sheet | Cash and cash equivalents | 39,536 |
| Balance sheet | Current assets | 118,675 |
| Balance sheet | Current liabilities | 203,113 |
| Balance sheet | Equity | 176,379 |
| Balance sheet | Share capital at nominal value | 2,500 |
| Balance sheet | Non-current assets | 303,812 |
| Balance sheet | Non-current liabilities | 42,995 |
| Balance sheet | Retained earnings (loss) from previous periods | 138,164 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -24,023 |
| Income statement scheme 1 | Labour costs | -320,432 |
| Income statement scheme 1 | Revenue | 651,969 |
| Income statement scheme 1 | Annual period profit / loss | 35,465 |
| Income statement scheme 1 | Operating profit (loss) | 43,345 |
| Income statement scheme 1 | Profit (loss) before income tax | 35,465 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 138,164 |
| Note: Labour costs | Employees | 11 |
| Note: Labour costs | Labour costs | 247,248 |
Linked company
Company: Asper Biogene OÜ